Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Monika Fischer"'
Autor:
Monika Fischer, Yao-Wen Cheng
Publikováno v:
Gastroenterology Clinics of North America. 49:739-752
"Patients with inflammatory bowel disease, including ulcerative colitis (UC) and Crohn disease, have altered gut microbiomes. The success of fecal microbiota transplantation (FMT) in the treatment of Clostridioides difficile infection, a disease that
Autor:
Abbinaya Elangovan, Monika Fischer
Publikováno v:
Current Opinion in Clinical Nutrition & Metabolic Care. 23:336-343
Purpose of review With the growing popularity and commercialization of probiotics, it is important to understand the implications of existing randomized controlled trials and their applicability in the clinical setting to treat luminal gastrointestin
Autor:
Monika Fischer, Yao-Wen Cheng
Publikováno v:
Expert Review of Anti-infective Therapy. 18:323-333
Introduction: Up to 15% of hospitalized patients with Clostridioides difficile infection (CDI) develop severe CDI (SCDI) or Fulminant CDI (FCDI). Due to high rates of mortality in medically-refractory CDI cases, 30% of patients with severe infection
Autor:
Vinod Kumar, Monika Fischer
Publikováno v:
Expert Opinion on Biological Therapy. 20:73-81
Introduction: Fecal microbiota transplantation (FMT) is a procedure involving transfer of stool from a healthy donor into the intestinal tract of a diseased recipient to restore intestinal microbia...
Autor:
Mary Njenga, Colleen R. Kelly, Majdi Osman, Kurt Warren, Zain Kassam, Kelsey O'Brien, Alim Ladha, Ryan J. Elliott, Shrish Budree, Jessica R. Allegretti, Monika Fischer
Publikováno v:
Gut Microbes
Gut Microbes, Vol 11, Iss 6, Pp 1806-1808 (2020)
Gut Microbes, Vol 11, Iss 6, Pp 1806-1808 (2020)
Fecal microbiota transplantation (FMT) is a recommended therapy to prevent recurrent Clostridioides difficile infection (CDI).1,2 Stool banks have emerged to enable safe widespread access by provid...
Autor:
Angela G. Juby, Tanya Monaghan, R Ennis-Davis, Karen J. Goodman, Monika Fischer, Emmalee Phelps, B McSweeney, Huiping Xu, Karen Wong, Benjamin H. Mullish, A Edmison, Brandi Roach, Allegretti, Carmen McLeod, R Chis, Elaine O. Petrof, Dina Kao
Publikováno v:
Gut Microbes
Gut Microbes, Vol 11, Iss 1, Pp 51-62 (2020)
Gut Microbes, Vol 11, Iss 1, Pp 51-62 (2020)
Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridioides difficile infection. Stool donors are essential, but difficult to recruit and retain. We aimed to identify factors influencing willingness to donate sto
Autor:
Benjamin H. Mullish, Monika Fischer, Jonathan Hurtado, Sashidhar Sagi, Zain Kassam, Colleen R. Kelly, Sara Nemes, Ari Grinspan, Michael Silverstein, Matthew Bohm, Will Pettee, James L. Alexander, Madeline Carrellas, Jesus Miguens Blanco, Julian Marchesi, Alexandros Pechlivanis, Emmalee Phelps, Jenna Marcus, Julie A. K. McDonald, Ylaine Gerardin, Kate Gallagher, Jessica R. Allegretti, Grace F. Barker
Publikováno v:
Inflamm Bowel Dis
Background Recurrent Clostridioides difficile infection (CDI) in patients with inflammatory bowel disease (IBD) is a clinical challenge. Fecal microbiota transplantation (FMT) has emerged as a recurrent CDI therapy. Anecdotal concerns exist regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::981de99c3ecbbf74c12b5d4d21b359c7
http://hdl.handle.net/10044/1/84552
http://hdl.handle.net/10044/1/84552
Autor:
Adam C. Ehrlich, Daniel McDonald, Ashish Atreja, Loren Laine, James D. Lewis, Lea Ann Chen, Razvan Arsenescu, Monika Fischer, Joel Pekow, Rob Knight, Eugene F. Yen, Jonathan Goldstein, Ari Grinspan, Sahil Khanna, David T. Rubin, Dea Hunsicker, Paul Feuerstadt, Carl V. Crawford, Sonya Serra, Jennifer Vincent, R. K. Hsu, Lyn Tangen, Alison M. Kim, Yanina Nersesova, Jessica R. Allegretti, Mark Mattar, Gary D. Wu, Imad Absah, Lydia Fredell, Thomas A. Moore, David H. Kerman, Stacy A. Kahn, Colleen R. Kelly
Publikováno v:
Gastroenterology
Gastroenterology, vol 160, iss 1
Gastroenterology, vol 160, iss 1
Background & aimsFecal microbiota transplantation (FMT) is used commonly for treatment of Clostridioides difficile infections (CDIs), although prospective safety data are limited and real-world FMT practice and outcomes are not well described. The FM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52fa643538eaba4ed47710fe636969e2
https://europepmc.org/articles/PMC8034505/
https://europepmc.org/articles/PMC8034505/
Publikováno v:
Expert opinion on biological therapy. 19(12)
Introduction: Alteration in the intestinal microbiota also termed as intestinal dysbiosis has been demonstrated in numerous gastrointestinal disorders linked to aberrant immune processes, acquisition of pathogenic organisms and often administration o
Autor:
Najwa El-Nachef, Zain Kassam, Lindsay Eysenbach, Jessica R. Allegretti, Monika Fischer, Colleen R Kelly
Publikováno v:
Inflammatory Bowel Diseases. 23:1710-1717
Fecal microbiota transplantation (FMT) has changed the standard of care for Clostridium difficile infection. However, there is limited data focusing on efficacy and safety profile of FMT in patients with C. difficile infection with underlying inflamm